Sphingolipid modulation of angiogenic factor expression in neuroblastoma.

@article{Li2011SphingolipidMO,
  title={Sphingolipid modulation of angiogenic factor expression in neuroblastoma.},
  author={Mei-Hong Li and Timothy Hla and Fernando Puig Ferrer},
  journal={Cancer prevention research},
  year={2011},
  volume={4 8},
  pages={1325-32}
}
Metabolism of sphingolipids into downstream lipid mediators followed by signaling modulates tumor microenvironment and the cancer cells to influence tumor progression. As such, sphingolipid signaling represents a novel way to modulate tumor biology. Neuroblastoma (NB), the most common extracranial solid tumor of childhood, is highly angiogenic and often displays poor prognosis. However, the role of sphingolipid mediators is not known in NB. We found that NB expresses high levels of sphingosine… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

FTY720 for cancer therapy (Review).

Oncology reports • 2013
View 6 Excerpts
Highly Influenced

Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma.

The Journal of pharmacology and experimental therapeutics • 2015
View 9 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology • 2010

Similar Papers

Loading similar papers…